Clara Rodríguez Fernández, Author at Labiotech.eu

About

Traveler, musician, food enthusiast and book worm. Always on the hunt for interesting facts and news.

Articles by Clara Rodríguez Fernández

News and Trends 30 Jun 2018

Glass Microbiology: From the Microscope to the Art Gallery

Artist Luke Jerram is behind Glass Microbiology, a series of beautiful glass-blown microbes that are changing the way we perceive viruses and bacteria. We’ve all seen at some point brightly-colored illustrations of viruses, most likely the feared HIV or an alien-like bacteriophage. These representations feed our imagination and help us understand the tiny but complex world of […]

June 30, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Duchenne muscular dystrophy Summit Therapeutics

News and Trends 28 Jun 2018

Muscular Dystrophy Drug Fails in Phase 2 Trial

The stock of Summit Therapeutics has plunged by 80% after announcing that its drug candidate for Duchenne muscular dystrophy failed to meet the primary and secondary endpoints of a Phase II clinical trial. Duchenne muscular dystrophy is a genetic disease that causes progressive muscle deterioration in children born with the disease. The British-American company Summit […]

June 28, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 27 Jun 2018

International Fund Raises €300M for Dementia Research

The Dementia Discovery Fund has raised $350M (€300M) to support industrial and academic scientists doing early-stage research to develop new dementia medicines. Launched in 2015, the Dementia Discovery Fund (DDF) is dedicated to investing in early-stage ventures that develop disease-modifying therapeutics for all types of dementia, including Alzheimer’s and Parkinson’s. Yesterday, the DDF completed a […]

June 27, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

gw pharmaceuticals fda epidiolex cannabinoid epilepsy

News and Trends 26 Jun 2018

Update: The FDA Approves First Cannabinoid Treatment for Epilepsy

Update (26/06/2018): The FDA has approved GW Pharmaceutical’s drug Epidiolex in two severe forms of epilepsy. The approval makes Epidolex the first prescription drug made from highly purified cannabidiol to reach the market. Published on 20/04/2018 GW Pharmaceuticals has received a unanimous recommendation from the FDA Advisory Committee Meeting supporting the approval of what could soon […]

June 26, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 22 Jun 2018

Next-Generation CAR-T Company Raises €130M on NASDAQ IPO

London-based Autolus has made its debut on the NASDAQ raising funds to boost the development of a next generation of CAR-T cell therapy for cancer. Founded in 2014 as a spin-out from University College London, Autolus has been taking great strides to develop its CAR-T technology. In less than four years, the company managed to raise nearly €150M […]

June 22, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Gates Foundation Oxitec Malaria Genetically Modified Mosquitoes

News and Trends 20 Jun 2018

Gates Foundation and Oxitec Fight Malaria with Genetically-Modified Mosquitoes

The Bill & Melinda Gates Foundation has partnered with Oxitec for the development of a new strain of genetically-modified mosquitoes that can help reduce the spread of malaria in America. In its latest effort to free the world of malaria, the Bill & Melinda Gates Foundation has joined forces with Oxitec, a British company that […]

June 20, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 19 Jun 2018

Biomaterial to Regenerate Teeth Approved in Europe

The Israeli company Datum Dental has received approval to launch a biomaterial for dental implants in Europe and Canada. Datum Dental has developed a biomaterial specifically designed to help the body regenerate real bone tissue after dental operations. Launched in the US last year, the biomaterial has now received CE marking in Europe and approval […]

June 19, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

pluristem cell therapy peripheral artery disease

News and Trends 13 Jun 2018

Placenta Cell Therapy Improves Mobility in Patients with Peripheral Artery Disease

The Israeli biotech Pluristem has Phase II data indicating that its cell therapy made of placenta cells can help patients suffering from peripheral artery disease recover their mobility. The trial, run in the US, Germany, South Korea and Israel, enrolled 172 patients with intermittent claudication, an early stage of peripheral artery disease where the legs […]

June 13, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 11 Jun 2018

Scientists Warn CRISPR Therapy Could Cause Cancer as First Human Trials Take Place

A study at Karolinska Institutet in Sweden has revealed that CRISPR-Cas9 gene editing could favor mutations in the most common cancer-causing gene. What does it mean for the first CRISPR therapy trials in humans? CRISPR-Cas9 has taken the life sciences field by storm, making gene editing simpler and faster than ever. Although CRISPR-Cas9 gene […]

June 11, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 8 Jun 2018

People with Innate Resistance to HIV Could Provide a Functional HIV Cure

In the process of studying HIV-infected patients who naturally don’t need therapy to control the virus, scientists have found what could become a functional cure for HIV infections. A team of researchers from France, Italy, the UK and Australia has identified a molecule that could be transferred to HIV-positive people to help […]

June 8, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

Interview 4 Jun 2018

Meet the German Biotech Behind Adidas’ Biodegradable Shoes

The synbio company AMSilk is drawing inspiration from nature to produce sustainable materials for applications ranging from clothing to medicine. I spoke to CEO Jens Klein to find out more about the innovative biodegradable material that has caught Adidas’ eye. In 2016, Adidas showed the world the first prototype of a new running shoe that, […]

June 4, 2018 - 5 minutesmins - By Clara Rodríguez Fernández

News and Trends 30 May 2018

Biotech in Germany Celebrates the Closing of a €300M Fund

High-Tech Gründerfonds (HTGF), a VC with a long track of biotech investments in Germany, has closed a new fund could benefit the country’s biotech scene. High-Tech Gründerfonds is a German VC that provides seed funding to high-tech startups, including several in the biotech space. The firm has now announced the final closing of a third […]

May 30, 2018 - 1 minutemin - By Clara Rodríguez Fernández

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Clara Rodríguez Fernández

About

Articles by Clara Rodríguez Fernández

Glass Microbiology: From the Microscope to the Art Gallery

Muscular Dystrophy Drug Fails in Phase 2 Trial

International Fund Raises €300M for Dementia Research

Update: The FDA Approves First Cannabinoid Treatment for Epilepsy

Next-Generation CAR-T Company Raises €130M on NASDAQ IPO

Gates Foundation and Oxitec Fight Malaria with Genetically-Modified Mosquitoes

Biomaterial to Regenerate Teeth Approved in Europe

Placenta Cell Therapy Improves Mobility in Patients with Peripheral Artery Disease

Scientists Warn CRISPR Therapy Could Cause Cancer as First Human Trials Take Place

People with Innate Resistance to HIV Could Provide a Functional HIV Cure

Meet the German Biotech Behind Adidas’ Biodegradable Shoes

Biotech in Germany Celebrates the Closing of a €300M Fund

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Clara Rodríguez Fernández

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!